| Net Cash Provided by (Used in) Operating Activities |
-1.36M |
USD |
-310% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
2M |
USD |
+1799% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-308K |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100M |
shares |
0% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
16.7M |
shares |
+4.61% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
329K |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
156K |
USD |
-53.7% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Valuation Allowance |
6.85M |
USD |
+9.95% |
Q4 2024 |
FY 2024 |
| Depreciation |
1.68K |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
5.69M |
USD |
+89.4% |
Q4 2023 |
FY 2023 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2023 |
Q2 2023 |
| Preferred Stock, Shares Authorized |
25M |
shares |
0% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
113M |
USD |
+324% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2023 |
Q2 2023 |
| Share-based Payment Arrangement, Expense |
0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
480K |
USD |
+7493% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |